Lawsuit alleges Lilly, Novo locked up telehealth to kill compounded GLP-1s – Sherwood News
Strive Specialties, one of the largest compounding pharmacies in the country, accused Eli Lilly and Novo Nordisk of locking up telehealth companies they partner with in an effort to cut off businesses like them from the GLP-1 market. Telehealth is one of the primary ways patients access weight-loss medications. Novo and Lilly have partnerships with…
